Rhino Biotech Limited
OTC: RBRXF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Nicholas W. Baxter
- Employees
- 1
- Headquarters
- South Hill, Anguilla
- IPO year
- 2005
- Market cap
- $3.1K
- Website
- https://ir.rhinobiotech.com
Loading RBRXF…
Loading profile data…Frequently asked questions about RBRXF
What does Rhino Biotech Limited (RBRXF) do?
Rhino Biotech Limited is dedicated to pioneering the development of health supplements sourced from plants and fungi, in addition to biopharmaceutical solutions designed for both disease prevention and treatment. The company adopted its current name, Rhino Biotech Limited, in September 2021, having previously operated as Eurasia Energy Limited....
Where does RBRXF trade?
Rhino Biotech Limited (RBRXF) trades on the Other OTC.
What sector is RBRXF in?
Rhino Biotech Limited (RBRXF) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Rhino Biotech Limited?
Nicholas W. Baxter is the chief executive officer of Rhino Biotech Limited (RBRXF).
Where is Rhino Biotech Limited headquartered?
Rhino Biotech Limited is headquartered in Anguilla.
Does RBRXF pay a dividend?
Rhino Biotech Limited (RBRXF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did RBRXF go public?
Rhino Biotech Limited (RBRXF) completed its initial public offering in 2005.